Epigral Limited Schedules Investor-Analyst Meet for April 13, 2026

1 min read     Updated on 09 Apr 2026, 05:58 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Epigral Limited has scheduled an investor and analyst meeting for April 13, 2026, organized by Sunidhi Securities & Finance Ltd. via video conferencing. The company has notified stock exchanges under SEBI Regulation 30, ensuring regulatory compliance. No unpublished price sensitive information will be shared during the meeting, and relevant presentations are available on the company's website.

powered bylight_fuzz_icon
37283310

*this image is generated using AI for illustrative purposes only.

Epigral Limited has announced an upcoming investor and analyst meeting, demonstrating its commitment to maintaining transparent communication with stakeholders. The company has formally notified stock exchanges about this scheduled interaction under regulatory compliance requirements.

Meeting Details and Schedule

The investor meeting has been organized by Sunidhi Securities & Finance Ltd. and will be conducted through video conferencing technology. The company has provided specific details about the upcoming interaction:

Parameter: Details
Meeting Type: Investors/Analysts meet organized by Sunidhi Securities & Finance Ltd.
Date: April 13, 2026
Mode: Video Conferencing (V.C.)
Location: Not Applicable

Regulatory Compliance and Transparency

Epigral Limited has fulfilled its regulatory obligations by informing both the National Stock Exchange of India Limited and BSE Limited about this meeting. The notification was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring proper disclosure to market participants.

The company has emphasized its commitment to maintaining information transparency by stating that no unpublished price sensitive information will be shared or discussed during the meeting with investors. This approach aligns with regulatory requirements and ensures fair disclosure practices.

Available Resources and Documentation

Epigral has made relevant presentation materials accessible to participants ahead of the meeting. The latest Earnings Presentation and Corporate Presentation that may be discussed during the session have already been placed on the company's official website at www.epigral.com . This proactive approach allows participants to review materials in advance and prepare for meaningful discussions.

Schedule Flexibility

The company has noted that the meeting schedule remains subject to change due to potential exigencies on the part of institutional investors or the company itself. This flexibility acknowledges the dynamic nature of corporate scheduling and ensures accommodation for unforeseen circumstances that may affect participation.

The formal notification was signed by Gaurang Trivedi, Company Secretary and Compliance Officer, on April 9, 2026, demonstrating proper corporate governance procedures in the communication process.

What key strategic initiatives or business developments is Epigral likely to discuss that could impact its stock performance post-meeting?

How might the outcomes of this investor meeting influence Epigral's future fundraising capabilities and institutional investor interest?

Will Epigral's engagement with Sunidhi Securities signal potential expansion of its investment banking relationships or advisory services?

Epigral Limited Schedules Video Conference Meeting with Dhamma Capital

1 min read     Updated on 09 Apr 2026, 05:27 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Epigral Limited has scheduled a video conference meeting with Dhamma Capital for April 10, 2026, as part of its investor engagement activities. The meeting follows SEBI regulatory compliance requirements and ensures no unpublished price sensitive information will be shared, with relevant presentations already available on the company website.

powered bylight_fuzz_icon
36830089

*this image is generated using AI for illustrative purposes only.

Epigral Limited has announced a scheduled one-on-one meeting with Dhamma Capital through video conferencing, demonstrating the company's continued commitment to maintaining transparent communication with its investor community. The meeting represents a structured approach to investor relations under regulatory compliance.

Meeting Details

The one-on-one meeting has been organized with specific parameters to ensure effective institutional investor engagement:

Parameter: Details
Investor: Dhamma Capital
Date: April 10, 2026
Format: One-on-One Meeting
Mode: Video Conferencing
Location: N.A.

Regulatory Compliance

The announcement has been made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework ensures that listed companies maintain appropriate disclosure standards when engaging with institutional investors. The company has emphasized that no unpublished price sensitive information will be shared or discussed during the meeting with investors.

Information Accessibility

Epigral Limited has confirmed that the latest earnings presentation and corporate presentation that may be discussed during the meeting have already been placed on the company's website at www.epigral.com . This proactive approach ensures that all relevant information is publicly accessible and maintains transparency in investor communications.

Schedule Flexibility

The company has noted that the schedule of the meeting is subject to change due to potential exigencies on the part of either the institutional investor or the company. This flexibility clause allows for necessary adjustments while maintaining the commitment to investor engagement. The formal communication was signed by Gaurang Trivedi, Company Secretary and Compliance Officer, on April 9, 2026.

Will Epigral Limited expand its investor outreach program to include more institutional investors following this structured engagement with Dhamma Capital?

How might Dhamma Capital's investment decision influence other institutional investors' interest in Epigral Limited's stock?

What strategic initiatives or business developments is Epigral likely to highlight in upcoming investor presentations to attract institutional funding?

More News on Epigral